Genetic diagnosis of familial breast cancer using clonal sequencing
- 2 February 2010
- journal article
- research article
- Published by Hindawi Limited in Human Mutation
- Vol. 31 (4) , 484-491
Abstract
Using conventional Sanger sequencing as a reference standard, we compared the sensitivity, specificity, and capacity of the Illumina GA II platform for the detection of TP53, BRCA1, and BRCA2 mutations in established tumor cell lines and DNA from patients with germline mutations. A total of 656 coding variants were identified in four cell lines and 65 patient DNAs. All of the known pathogenic mutations (including point mutations and insertions/deletions of up to 16 nucleotides) were identified, using a combination of the Illumina data analysis pipeline with custom and commercial sequence alignment software. In our configuration, clonal sequencing outperforms current diagnostic methods, providing a reduction in analysis times and in reagent costs compared with conventional sequencing. These improvements open the possibility of BRCA1/2 testing for a wider spectrum of at-risk women, and will allow the genetic classification of tumors prior to the use of novel PARP inhibitors to treat BRCA-deficient breast cancers. Hum Mutat 31:1–8, 2010.Keywords
This publication has 19 references indexed in Scilit:
- Genetic diagnosis by whole exome capture and massively parallel DNA sequencingProceedings of the National Academy of Sciences, 2009
- Direct to consumer genetic testing: Avoiding a culture warGenetics in Medicine, 2009
- Direct-to-Consumer Genetic Testing: Failure Is Not an OptionClinical Pharmacology & Therapeutics, 2009
- Semi-Automated Unidirectional Sequence Analysis for Mutation Detection in a Clinical Diagnostic SettingGenetic Testing and Molecular Biomarkers, 2009
- Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencingNature Biotechnology, 2009
- Accurate whole human genome sequencing using reversible terminator chemistryNature, 2008
- Identification of genetic variants using bar-coded multiplexed sequencingNature Methods, 2008
- Direct selection of human genomic loci by microarray hybridizationNature Methods, 2007
- PARP inhibitors for cancer therapyExpert Reviews in Molecular Medicine, 2005
- Base-Calling of Automated Sequencer Traces UsingPhred. I. Accuracy AssessmentGenome Research, 1998